Literature DB >> 11508511

Allergic rhinitis does not constitute a risk factor for obstructive sleep apnea syndrome.

M F Kramer1, R De La Chaux, A Dreher, E Pfrogner, G Rasp.   

Abstract

Obstructive sleep apnea syndrome (OSAS) is a condition characterized by recurrent episodes of obstruction of the upper airway. The aim of this study was to evaluate whether nasal obstruction due to allergic rhinitis constitutes a risk factor for OSAS. Patients (n = 119) presenting typical symptoms of sleep apnea were tested for OSAS using polysomnography. Additionally all patients were tested in vivo and in vitro (including nasal eosinophilic cationic protein) for allergic rhinitis. Examination for allergic rhinitis revealed that 88.3% of all patients had no allergic rhinitis, whereas only 11.7% were diagnosed as allergic. No significant differences in sleeping parameters were observed between allergic and non-allergic patients. Comparison of parameters indicative of relevant OSAS (apnea-hypopnea index [AHI] > 10) revealed that 60% of non-allergic patients had relevant OSAS, compared to only 50% of allergic patients. Investigation of allergic subgroups revealed similar results: no significant differences in sleeping parameters or elevated rates of relevant OSAS parameters were observed, especially in perennial allergic rhinitis due to house dust mites. No elevated rates of allergic rhinitis were observed in the studied cohort of patients suffering from sleep apnea or OSAS. Furthermore, no significant differences in sleeping behavior or polysomnography parameters were found on comparing allergic and non-allergic patients. In summary, our data rule out allergic rhinitis as a major risk factor for OSAS.

Entities:  

Mesh:

Year:  2001        PMID: 11508511

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  8 in total

1.  Peculiarities of clinical profile of snoring and mild to moderate obstructive sleep apnea-hypopnea syndrome patients.

Authors:  Tomas Balsevičius; Virgilijus Uloza; Raimundas Sakalauskas; Skaidrius Miliauskas
Journal:  Sleep Breath       Date:  2011-09-03       Impact factor: 2.816

2.  Polysomnographic findings in persistent allergic rhinitis.

Authors:  Bulent Bozkurt; K Serife Ugur; Harun Karamanli; Fatma Kucuker; Duygu Ozol
Journal:  Sleep Breath       Date:  2016-08-01       Impact factor: 2.816

Review 3.  Congestion and sleep impairment in allergic rhinitis.

Authors:  Timothy J Craig; Amir Sherkat; Sahar Safaee
Journal:  Curr Allergy Asthma Rep       Date:  2010-03       Impact factor: 4.806

4.  Impact of nasal obstruction on sleep quality: a community-based study of women.

Authors:  Caroline Bengtsson; Lars Jonsson; Mats Holmström; Malin Svensson; Jenny Theorell-Haglöw; Eva Lindberg
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-05-05       Impact factor: 2.503

5.  Intranasal corticosteroid therapy for obstructive sleep apnoea in patients with co-existing rhinitis.

Authors:  J L Kiely; P Nolan; W T McNicholas
Journal:  Thorax       Date:  2004-01       Impact factor: 9.139

6.  Allergy-related outcomes and sleep-related disorders in adults: a cross-sectional study based on NHANES 2005-2006.

Authors:  Yang Xi; Yu-Qin Deng; Shi-Ming Chen; Yong-Gang Kong; Yu Xu; Fen Li; Wo-Er Jiao; Gan Lu; Ze-Zhang Tao
Journal:  Allergy Asthma Clin Immunol       Date:  2022-03-22       Impact factor: 3.406

Review 7.  Allergic rhinitis and sleep disorders in children - coexistence and reciprocal interactions.

Authors:  Cláudio D'Elia; David Gozal; Oliviero Bruni; Ekaterini Goudouris; Miguel Meira E Cruz
Journal:  J Pediatr (Rio J)       Date:  2021-12-31       Impact factor: 2.990

8.  Diagnosis of Obstructive Sleep Apnea in Patients with Allergic and Non-Allergic Rhinitis.

Authors:  Annalisa Pace; Giannicola Iannella; Valeria Rossetti; Irene Claudia Visconti; Giampiero Gulotta; Carlo Cavaliere; Andrea De Vito; Antonino Maniaci; Salvatore Cocuzza; Giuseppe Magliulo; Andrea Ciofalo
Journal:  Medicina (Kaunas)       Date:  2020-09-08       Impact factor: 2.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.